These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 24918556

  • 1. Safety and efficacy comparison of minocycline microgranules vs lymecycline in the treatment of mild to moderate acne: randomized, evaluator-blinded, parallel, and prospective clinical trial for 8 weeks.
    Ocampo-Candiani J, Velazquez-Arenas LL, de la Fuente-Garcia A, Trevino-Gomezharper C, Berber A.
    J Drugs Dermatol; 2014 Jun; 13(6):671-6. PubMed ID: 24918556
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris.
    Grosshans E, Belaïch S, Meynadier J, Alirezai M, Thomas L.
    Eur J Dermatol; 1998 Jun; 8(3):161-6. PubMed ID: 9649660
    [Abstract] [Full Text] [Related]

  • 3. Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline.
    Bossuyt L, Bosschaert J, Richert B, Cromphaut P, Mitchell T, Al Abadie M, Henry I, Bewley A, Poyner T, Mann N, Czernielewski J.
    Eur J Dermatol; 2003 Jun; 13(2):130-5. PubMed ID: 12695127
    [Abstract] [Full Text] [Related]

  • 4. Lymecycline and minocycline in inflammatory acne: a randomized, double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy.
    Piérard-Franchimont C, Goffin V, Arrese JE, Martalo O, Braham C, Slachmuylders P, Piérard GE.
    Skin Pharmacol Appl Skin Physiol; 2002 Jun; 15(2):112-9. PubMed ID: 11867968
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
    Dréno B, Kaufmann R, Talarico S, Torres Lozada V, Rodríguez-Castellanos MA, Gómez-Flores M, De Maubeuge J, Berg M, Foley P, Sysa-Jedrzejowska A, Kerrouche N, Paliargues F, Bettoli V.
    Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle.
    Cunliffe WJ, Meynadier J, Alirezai M, George SA, Coutts I, Roseeuw DI, Hachem JP, Briantais P, Sidou F, Soto P.
    J Am Acad Dermatol; 2003 Sep; 49(3 Suppl):S218-26. PubMed ID: 12963898
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A, Chu A, Goulden V, Ambroziak M.
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R, Rizer R, Barba A, Wilson D, Stewart D, Grossman R, Nighland M, Weiss J.
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [Abstract] [Full Text] [Related]

  • 15. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE, Eady EA, Popescu C, Newton J, Li WA.
    Cochrane Database Syst Rev; 2003 Jun; (1):CD002086. PubMed ID: 12535427
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium.
    Leyden JJ, Bruce S, Lee CS, Ling M, Sheth PB, Stewart DM, Werschler WP, Gilbert RD, Kircik L.
    J Drugs Dermatol; 2013 Jun 01; 12(6):658-63. PubMed ID: 23839182
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of a new extended-release formulation of minocycline.
    Fleischer AB, Dinehart S, Stough D, Plott RT, Solodyn Phase 2 Study Group, Solodyn Phase 3 Study Group.
    Cutis; 2006 Oct 01; 78(4 Suppl):21-31. PubMed ID: 17436826
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study.
    Raoof TJ, Hooper D, Moore A, Zaiac M, Sullivan T, Kircik L, Lain E, Jankicevic J, Stuart I.
    J Am Acad Dermatol; 2020 Apr 01; 82(4):832-837. PubMed ID: 31163231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.